Metagenomi, Inc. (MGX)

Metagenomi Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-88.74	-78.06	-68.26	-43.59	-21.44
Depreciation & Amortization	5.48	5.41	4.21	1.73	0.39
Asset Writedown & Restructuring Costs	0.93	1.04	0.02	0.28	-
Loss (Gain) From Sale of Investments	4.55	3.02	-11.34	-1.22	-2.56
Stock-Based Compensation	12.57	16.2	6.92	1.96	0.38
Other Operating Activities	4.89	2.98	3.47	1.08	1.24
Change in Accounts Receivable	-0.37	1.19	-1.18	-1.27	-
Change in Accounts Payable	-1.86	-1.11	-0.08	0.72	0.7
Change in Unearned Revenue	-26.43	-46.8	-30.3	65.66	44.23
Change in Income Taxes	-	-3.27	1.73	1.54	-
Change in Other Net Operating Assets	-2.64	-9.69	3.4	2.84	1.33
Operating Cash Flow	-91.62	-109.07	-91.41	29.72	24.26
Operating Cash Flow Growth	-	-	-	22.54%	-
Capital Expenditures	-0.82	-3.11	-9.81	-13.98	-2.9
Investment in Securities	100.49	-85.04	55.55	-108.22	-71.41
Investing Cash Flow	99.71	-88.16	45.73	-122.2	-74.32
Long-Term Debt Issued	-	-	-	-	29.97
Net Debt Issued (Repaid)	-	-	-	-	29.97
Issuance of Common Stock	0.11	84.01	-	-	-
Other Financing Activities	-0.54	-	-3.28	-	-
Financing Cash Flow	-0.43	84.01	1.01	239.59	39.92
Net Cash Flow	7.66	-113.22	-44.66	147.12	-10.14
Free Cash Flow	-92.45	-112.19	-101.22	15.75	21.35
Free Cash Flow Growth	-	-	-	-26.26%	-
Free Cash Flow Margin	-299.05%	-214.53%	-226.17%	91.55%	8787.65%
Free Cash Flow Per Share	-2.48	-3.40	-29.73	4.63	3.75
Cash Interest Paid	-	-	-	2.16	1.45
Cash Income Tax Paid	3.51	3.51	2.25	-	-
Levered Free Cash Flow	-55.43	-73.35	-31.65	-19.71	-
Unlevered Free Cash Flow	-55.43	-73.35	-31.65	-19.65	-
Change in Working Capital	-31.31	-59.67	-26.43	69.49	46.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q